Literature DB >> 20521220

Epigenetic signatures in cancer: Implications for the control of cancer in the clinic.

Sheila C S Lima1, Hector Hernandez-Vargas, Zdenko Herceg.   

Abstract

Significant progress in the field of cancer epigenetics has enhanced the understanding of epigenetic mechanisms in cellular processes and in abnormal events involved in tumorigenesis. Many studies have investigated epigenetic alterations in cancer cells and have revealed that epigenetic deregulation is important for the development of malignancy. These studies have also demonstrated that epigenetic changes are present in almost every human cancer, and that different cancers may harbor a specific 'epigenetic signature', which can be used for cancer control. This review focuses on studies that have revealed the existence of specific epigenetic changes related to particular cancer types and associated risk-factor exposures, and how these epigenetic signatures may be exploited in the diagnosis, treatment and prevention of cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20521220

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  11 in total

1.  Cell specific patterns of methylation in the human placenta.

Authors:  Ariadna Grigoriu; Jose Carlos Ferreira; Sanaa Choufani; Dora Baczyk; John Kingdom; Rosanna Weksberg
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 2.  Deciphering the epigenetic code: an overview of DNA methylation analysis methods.

Authors:  Muhammad Umer; Zdenko Herceg
Journal:  Antioxid Redox Signal       Date:  2013-01-22       Impact factor: 8.401

Review 3.  Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications.

Authors:  Yi Cao
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

Review 4.  How does the social environment during life course embody in and influence the development of cancer?

Authors:  Ming Chen; Huiyun Zhu; Yiqi Du; Geliang Yang
Journal:  Int J Public Health       Date:  2018-06-11       Impact factor: 3.380

5.  Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.

Authors:  Walter Pavicic; Esa Perkiö; Sippy Kaur; Päivi Peltomäki
Journal:  Mol Med       Date:  2011-02-09       Impact factor: 6.354

Review 6.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

7.  Tanshinones inhibit the growth of breast cancer cells through epigenetic modification of Aurora A expression and function.

Authors:  Yi Gong; Yanli Li; Hamid M Abdolmaleky; Linglin Li; Jin-Rong Zhou
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

8.  From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

Authors:  Marion Martin; Zdenko Herceg
Journal:  Genome Med       Date:  2012-01-31       Impact factor: 11.117

9.  Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study.

Authors:  Cheng-Lan Jiang; Shui-Wang He; Yun-Dong Zhang; He-Xian Duan; Tao Huang; Yun-Chao Huang; Gao-Feng Li; Ping Wang; Li-Ju Ma; Guang-Biao Zhou; Yi Cao
Journal:  Oncotarget       Date:  2017-01-03

10.  Comparing the Predictivity of Human Placental Gene, microRNA, and CpG Methylation Signatures in Relation to Perinatal Outcomes.

Authors:  Jeliyah Clark; Vennela Avula; Caroline Ring; Lauren A Eaves; Thomas Howard; Hudson P Santos; Lisa Smeester; Jacqueline T Bangma; Thomas Michael O'Shea; Rebecca C Fry; Julia E Rager
Journal:  Toxicol Sci       Date:  2021-09-28       Impact factor: 4.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.